Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.84 USD | +7.42% | -3.16% | -23.75% |
May. 20 | Chinese Regulator Approves Zai Lab’s New Drug Application for Bacterial Pneumonia Drug | MT |
May. 20 | Zai Lab, Innoviva Subsidiary Receive China Approval for Hospital Infection Treatment | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.75% | 2.07B | |
-3.15% | 89.69B | |
+3.95% | 41.34B | |
-10.51% | 33.72B | |
+59.25% | 26.11B | |
-20.09% | 14.63B | |
-8.92% | 12.84B | |
-11.46% | 11.66B | |
-43.05% | 11.52B | |
+4.34% | 8.92B |
- Stock Market
- Equities
- ZLAB Stock
- News Zai Lab Limited
- Transcript : Zai Lab Limited, Q4 2021 Earnings Call, Mar 02, 2022